Stock Updates

How has Boston Scientific Corporation:(NYSE:BSX) performed recently?

Boston Scientific Corporation (NYSE: BSX) is a large market cap stock with a market cap of 31561.01. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 18.84 and EPS of -0.03. At a stock price of 23.3 (-0.47%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 24.00%, more recently this last year it has grown by -98.30%. The next year growth is going to be about 13.28% and more long-term 12.70% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been -0.90% and sales growth quarter over quarter is 11.10%.

For performance, Boston Scientific Corporation the past week has seen a gain of 6.01%. For the last month performance for Boston Scientific Corporation is 2.19%. While the last quarter is 21.54% and half year, 29.52%. Finally for the year, performance is 32.76%.

The 52-week high for Boston Scientific Corporation, is at -0.81%, and for the 52-week low it comes to a value of 64.32%. The 20-day simple moving average is 4.32% and 22.90% for the 200-day simple moving average.

Volatility for the week is at 1.40%, and for the month it is 1.54%. Boston Scientific Corporation, has a target price of 24.46.

In terms of debt, long term debt/equity is 0.84, and for total debt/equity Boston Scientific Corporation has 0.88. The gross margin is 71.40%, while operating margin is -0.80%, the profit margin is -0.50%. The current ratio is 1.2 and the quick ratio is 0.8.

Insider ownership is at 0.50%, with instituitional ownership at 95.40%. Boston Scientific Corporation has a payout ratio of *TBA. With the total shares outstanding coming to 1354.55. The shares float is 1345.45, with the float short at 1.75%, with short ratio coming to 2.08.

In terms of returns, the return on assets see Boston Scientific Corporation, get -0.20%, with its returns on investment at 0.70%. Return on equity is -0.60%. So will the investors see the target price of 24.46, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Tony Dabbs

Leave a Comment